Abbott Laboratories Gestion
Gestion contrôle des critères 3/4
Le PDG Abbott Laboratories est Robert Ford, nommé en Oct2018, a un mandat de 6.08 ans. La rémunération annuelle totale est $ 23.27M, composée du salaire de 6.4% et des bonus 93.6%, y compris les actions et options de la société. détient directement 0.024% des actions de la société, d'une valeur de $ 48.76M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 5.8 ans et 5.8 ans.
Informations clés
Robert Ford
Directeur général
US$23.3m
Rémunération totale
Pourcentage du salaire du PDG | 6.4% |
Durée du mandat du directeur général | 6.1yrs |
Propriété du PDG | 0.02% |
Durée moyenne d'occupation des postes de direction | 5.8yrs |
Durée moyenne du mandat des membres du conseil d'administration | 5.8yrs |
Mises à jour récentes de la gestion
Recent updates
Investors Will Want Abbott Laboratories' (NYSE:ABT) Growth In ROCE To Persist
Oct 31Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation
Oct 21Abbott: Challenging Comparables, Unappealing Value Limit The Incentive To Go Long Ahead Of Q3 Event
Oct 14Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet?
Oct 11Why We're Not Concerned About Abbott Laboratories' (NYSE:ABT) Share Price
Sep 27Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Sep 11A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Aug 16Abbott Laboratories: Driving Value By Scaling Innovations
Aug 13Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors
Aug 05Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
Jul 13These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well
Jul 01Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price
Jun 18Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)
Jun 04Abbott Laboratories: Why I Agree With Wall Street On This One
Jun 04Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
May 18Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings
Apr 17Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Apr 15Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now
Mar 21Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger
Mar 19Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly
Mar 06Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024
Feb 27Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon
Feb 08The King Is Back: Abbott Laboratories' Path To >11% Annual Returns
Jan 29The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts
Jan 26Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$6b |
Jun 30 2024 | n/a | n/a | US$6b |
Mar 31 2024 | n/a | n/a | US$6b |
Dec 31 2023 | US$23m | US$2m | US$6b |
Sep 30 2023 | n/a | n/a | US$5b |
Jun 30 2023 | n/a | n/a | US$5b |
Mar 31 2023 | n/a | n/a | US$6b |
Dec 31 2022 | US$22m | US$2m | US$7b |
Sep 30 2022 | n/a | n/a | US$8b |
Jun 30 2022 | n/a | n/a | US$9b |
Mar 31 2022 | n/a | n/a | US$8b |
Dec 31 2021 | US$25m | US$1m | US$7b |
Sep 30 2021 | n/a | n/a | US$7b |
Jun 30 2021 | n/a | n/a | US$6b |
Mar 31 2021 | n/a | n/a | US$6b |
Dec 31 2020 | US$20m | US$1m | US$4b |
Sep 30 2020 | n/a | n/a | US$3b |
Jun 30 2020 | n/a | n/a | US$3b |
Mar 31 2020 | n/a | n/a | US$4b |
Dec 31 2019 | US$12m | US$1m | US$4b |
Sep 30 2019 | n/a | n/a | US$3b |
Jun 30 2019 | n/a | n/a | US$3b |
Mar 31 2019 | n/a | n/a | US$3b |
Dec 31 2018 | US$8m | US$784k | US$2b |
Sep 30 2018 | n/a | n/a | US$802m |
Jun 30 2018 | n/a | n/a | US$812m |
Mar 31 2018 | n/a | n/a | US$365m |
Dec 31 2017 | US$5m | US$675k | US$344m |
Rémunération vs marché: La rémunération totale de Robert ($USD 23.27M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 12.67M ).
Rémunération et revenus: La rémunération de Robert a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Robert Ford (50 yo)
6.1yrs
Titularisation
US$23,268,171
Compensation
Mr. Robert B. Ford has been the Chief Executive Officer of Abbott Laboratories since March 31, 2020 and also serves as its Chairman of the Board since December 10, 2021. He has been President at Abbott Lab...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chairman of the Board | 6.1yrs | US$23.27m | 0.024% $ 48.8m | |
CFO & Executive VP of Finance | 1.2yrs | US$3.32m | 0.0023% $ 4.6m | |
Executive VP | 11.8yrs | US$7.42m | 0.011% $ 21.6m | |
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 10.2yrs | US$5.93m | 0.0073% $ 14.7m | |
Executive VP & Group President of Medical Devices | 5.8yrs | US$5.50m | 0.0035% $ 7.2m | |
Senior VP of Business & Technology Services and Chief Information Officer | less than a year | pas de données | pas de données | |
Vice President of Investor Relations. | no data | pas de données | pas de données | |
VP and Chief Ethics & Compliance Officer | no data | pas de données | pas de données | |
Vice President of Public Affairs & Corporate Marketing | no data | pas de données | pas de données | |
Senior Vice President of Commercial Operations | 1.8yrs | pas de données | pas de données | |
Executive Vice President of Human Resources | 5.3yrs | pas de données | 0.0059% $ 12.0m | |
Executive Vice President of Diabetes Care | 9.4yrs | pas de données | 0.0042% $ 8.4m |
5.8yrs
Durée moyenne de l'emploi
54yo
Âge moyen
Gestion expérimentée: L'équipe dirigeante de ABT est chevronnée et expérimentée (5.8 années d'ancienneté moyenne).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chairman of the Board | 5yrs | US$23.27m | 0.024% $ 48.8m | |
Independent Director | 7.8yrs | US$349.29k | 0.39% $ 783.7m | |
Independent Director | 7.8yrs | US$341.96k | 0.00020% $ 405.2k | |
Lead Independent Director | 12.9yrs | US$405.96k | 0.00027% $ 547.0k | |
Independent Director | 3.6yrs | US$337.96k | 0% $ 0 | |
Independent Director | 16.1yrs | US$441.44k | 0% $ 0 | |
Independent Director | 1.6yrs | US$283.96k | 0% $ 0 | |
Independent Director | 6.4yrs | US$331.96k | 0.00018% $ 364.7k | |
Independent Director | 12.9yrs | US$362.60k | 0.00015% $ 303.9k | |
Independent Director | 2.2yrs | US$354.96k | 0% $ 0 | |
Independent Director | 5.2yrs | US$331.19k | 0% $ 0 | |
Independent Director | 3.3yrs | US$356.96k | 0% $ 0 |
5.8yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ABT sont considérés comme expérimentés (ancienneté moyenne 5.8 ans).